Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos
| Ano de defesa: | 2014 |
|---|---|
| Autor(a) principal: | |
| Orientador(a): | |
| Banca de defesa: | , , |
| Tipo de documento: | Dissertação |
| Tipo de acesso: | Acesso aberto |
| dARK ID: | ark:/38995/0013000008m7b |
| Idioma: | por |
| Instituição de defesa: |
Universidade Federal de Goiás
|
| Programa de Pós-Graduação: |
Programa de Pós-graduação em Química (IQ)
|
| Departamento: |
Instituto de Química - IQ (RG)
|
| País: |
Brasil
|
| Palavras-chave em Português: | |
| Palavras-chave em Inglês: | |
| Área do conhecimento CNPq: | |
| Link de acesso: | http://repositorio.bc.ufg.br/tede/handle/tede/7185 |
Resumo: | The commercialization of drugs most often occurs through their solid forms, and the caracteriscas of drugs should be kept throughout the process of production and storage. Upon this fact the characterization studies of the drugs in the solid state are in constant growth. NMR solid state high resolution can provide important complementary information current techniques, through the changes of the chemical shifts.The objective of this study is the characterization of the drug efavirenz (EVZ) and oseltamivir by the technique of nuclear magnetic resonance both in solution and solid state data together with the theoretical computations. Efavirenz drug was characterized by X diffraction (XRD), nuclear magnetic resonance in solution (1H NMR and 13C {1H}) and solid (CPMAS NMR and 13C CPTOSS e15N), and the use of theoretical calculations in solution GIAO using the model for unambiguous assignment of NMR signals. The same techniques of structural characterization and theoretical calculations were used in drug Oseltamivir, reeking the technique of X diffraction (XRD), and this drug hitherto considered amorphous.The experimental data obtained by NMR analyzes were consistent with the structure of drug efavirenz and oseltamivir; and the results of theoretical calculations were tabulated, a work of statistical analysis is performed in order to correlate the experimental data with the theoretical data, the analysis of the standard deviation (SD), mean deviation (MD), linear coefficient (R) . Notably, the theoretical values of the chemical shifts of 1H and 13C NMR in solution, obtained at the level of theory DFT/B3LYP, allowed for the drugs in question a considerable correlation with experimental values and permitted to associate a low computational cost of a good precision results.Thus using NMR experiments in solution 1D and 2D allies the results of computational theoretical calculations was possible the elucidation and assignment of all NMR signals of 1H and 13C of both drugs. efined experiments 1D solid state NMR (CP / TOSS and 13C CP / MASS de15N) allowed identification of these atoms in the solid state. Combined with theoretical calculations GIPAW provided valuable information on the molecules within the asymmetric unit of each drug. |
| id |
UFG-2_cdfa8ab700e517592118bd2ff5eecd07 |
|---|---|
| oai_identifier_str |
oai:repositorio.bc.ufg.br:tede/7185 |
| network_acronym_str |
UFG-2 |
| network_name_str |
Repositório Institucional da UFG |
| repository_id_str |
|
| spelling |
Queiroz Junior, Luiz Henrique Kenghttp://lattes.cnpq.br/5071272851467384Martins, Felipe Terrahttp://lattes.cnpq.br/0466799995060671Queiroz Junior, Luiz Henrique KengColnago, Luiz AlbertoLião, Luciano Moraishttp://lattes.cnpq.br/5383109693086058Rodrigues, Diego Alves2017-04-19T14:24:54Z2014-09-01RODRIGUES, D. A. Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos. 2014. 97 f. Dissertação (Mestrado em Química) - Universidade Federal de Goiás, Goiânia, 2014.http://repositorio.bc.ufg.br/tede/handle/tede/7185ark:/38995/0013000008m7bThe commercialization of drugs most often occurs through their solid forms, and the caracteriscas of drugs should be kept throughout the process of production and storage. Upon this fact the characterization studies of the drugs in the solid state are in constant growth. NMR solid state high resolution can provide important complementary information current techniques, through the changes of the chemical shifts.The objective of this study is the characterization of the drug efavirenz (EVZ) and oseltamivir by the technique of nuclear magnetic resonance both in solution and solid state data together with the theoretical computations. Efavirenz drug was characterized by X diffraction (XRD), nuclear magnetic resonance in solution (1H NMR and 13C {1H}) and solid (CPMAS NMR and 13C CPTOSS e15N), and the use of theoretical calculations in solution GIAO using the model for unambiguous assignment of NMR signals. The same techniques of structural characterization and theoretical calculations were used in drug Oseltamivir, reeking the technique of X diffraction (XRD), and this drug hitherto considered amorphous.The experimental data obtained by NMR analyzes were consistent with the structure of drug efavirenz and oseltamivir; and the results of theoretical calculations were tabulated, a work of statistical analysis is performed in order to correlate the experimental data with the theoretical data, the analysis of the standard deviation (SD), mean deviation (MD), linear coefficient (R) . Notably, the theoretical values of the chemical shifts of 1H and 13C NMR in solution, obtained at the level of theory DFT/B3LYP, allowed for the drugs in question a considerable correlation with experimental values and permitted to associate a low computational cost of a good precision results.Thus using NMR experiments in solution 1D and 2D allies the results of computational theoretical calculations was possible the elucidation and assignment of all NMR signals of 1H and 13C of both drugs. efined experiments 1D solid state NMR (CP / TOSS and 13C CP / MASS de15N) allowed identification of these atoms in the solid state. Combined with theoretical calculations GIPAW provided valuable information on the molecules within the asymmetric unit of each drug.A comercialização de medicamentos na maioria das vezes ocorre mediante suas formas sólidas, sendo que as caracteriscas dos fármacos devem ser conservadas durante todo processo de produção e estocagem. Mediante este fato os estudos de caracterização dos fármacos em estado sólido estão em constante crescimento. A RMN em estado sólido de alta resolução pode fornecer informações complementares importantes as atuais técnicas, através das mudanças dos deslocamentos químicos. O objetivo deste presente estudo é a caracterização dos fármacos Efavirenz (EVZ) e Oseltamivir pela técnica de ressonância magnética nuclear tanto em solução como em estado sólido aliado aos dados teóricos de cálculos computacionais. O fármaco Efavirenz foi caracterizado por Difratometria de raios X (DRX), ressonância magnética nuclear em solução (RMN de 1H e 13C{1H}) e de sólidos (RMN CPMAS e CPTOSS de 13C e15N), além do uso de cálculos teóricos em solução utilizando o modelo GIAO para uma atribuição inequívoca dos sinais de RMN. As mesmas técnicas de caracterização estrutural e cálculos teóricos foram utilizadas no fármaco Oseltamivir, rescendendo a técnica de Difratometria de raios X (DRX), sendo este fármaco até então considerado amorfo. Os dados obtidos pelas análises experimentais de RMN foram coerentes com a estrutura dos fármacos Efavirenz e Oseltamivir; e os resultados dos cálculos teóricos foram dispostos em tabelas, sendo realizado um trabalho de análises estatísticas de forma a correlacionar os dados experimentais com os dados teóricos, pela análise do desvio padrão (SD), desvio médio (MD), coeficiente linear (R). Notavelmente os valores teóricos dos deslocamentos químicos de RMN 1H e 13C em solução, obtidos com o nível de teoria DFT/B3LYP, possibilitaram para os fármacos em questão uma correlação considerável com os valores experimentais e permitiram associar um baixo custo computacional a uma boa precisão dos resultados obtidos. Desta forma utilizando experimentos de RMN em solução 1D e 2D aliados aos resultados dos cálculos teóricos computacionais foi possível a elucidação e atribuição de todos os sinais de RMN de 1H e 13C de ambos os fármacos. Experimentos refinados de RMN em estado sólido 1D (CP/TOSS de 13C e CP/MASS de15N) possibilitaram a identificação destes átomos em estado sólido. Aliados a cálculos teóricos GIPAW forneceram valiosas informações sobre as moléculas dentro da unidade assimétrica de cada fármaco.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESapplication/pdfporUniversidade Federal de GoiásPrograma de Pós-graduação em Química (IQ)UFGBrasilInstituto de Química - IQ (RG)http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessRMN em estado sólidoEfavirenz (EVZ)OseltamivirCálculos teóricos computacionaisSolid state NMREfavirenz (EVZ)OseltamivirComputational theoretical calculationsCIENCIAS EXATAS E DA TERRA::QUIMICACaracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricosCharacterization of the crystalline phase of efavirenz and oseltamivir antiviral by NMR and theoretical calculationsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis663693921325415158600600600600782606674374119727815717003253031171952075167498588264571reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGLICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://repositorio.bc.ufg.br/tede/bitstreams/96beb7a3-b407-49f6-a0fd-830688cd2cec/downloadbd3efa91386c1718a7f26a329fdcb468MD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://repositorio.bc.ufg.br/tede/bitstreams/c19efe5a-17ec-4b82-9b40-bdfb69a296f6/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-80http://repositorio.bc.ufg.br/tede/bitstreams/eb9eb9dc-c505-4d92-b924-87ea5debe114/downloadd41d8cd98f00b204e9800998ecf8427eMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-80http://repositorio.bc.ufg.br/tede/bitstreams/f1543613-8bd2-48b6-bf88-5d7ace88ae3c/downloadd41d8cd98f00b204e9800998ecf8427eMD54ORIGINALDissertação - Diego Alves Rodrigues - 2014.pdfDissertação - Diego Alves Rodrigues - 2014.pdfapplication/pdf3563553http://repositorio.bc.ufg.br/tede/bitstreams/2b847c8d-f354-49be-8744-d8816de2fd91/download740d277eef5f559b08bdd1742e750f6eMD55tede/71852017-04-19 11:24:54.201http://creativecommons.org/licenses/by-nc-nd/4.0/Acesso Abertoopen.accessoai:repositorio.bc.ufg.br:tede/7185http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttps://repositorio.bc.ufg.br/tedeserver/oai/requestgrt.bc@ufg.bropendoar:oai:repositorio.bc.ufg.br:tede/12342017-04-19T14:24:54Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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 |
| dc.title.por.fl_str_mv |
Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos |
| dc.title.alternative.eng.fl_str_mv |
Characterization of the crystalline phase of efavirenz and oseltamivir antiviral by NMR and theoretical calculations |
| title |
Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos |
| spellingShingle |
Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos Rodrigues, Diego Alves RMN em estado sólido Efavirenz (EVZ) Oseltamivir Cálculos teóricos computacionais Solid state NMR Efavirenz (EVZ) Oseltamivir Computational theoretical calculations CIENCIAS EXATAS E DA TERRA::QUIMICA |
| title_short |
Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos |
| title_full |
Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos |
| title_fullStr |
Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos |
| title_full_unstemmed |
Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos |
| title_sort |
Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos |
| author |
Rodrigues, Diego Alves |
| author_facet |
Rodrigues, Diego Alves |
| author_role |
author |
| dc.contributor.advisor1.fl_str_mv |
Queiroz Junior, Luiz Henrique Keng |
| dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/5071272851467384 |
| dc.contributor.advisor-co1.fl_str_mv |
Martins, Felipe Terra |
| dc.contributor.advisor-co1Lattes.fl_str_mv |
http://lattes.cnpq.br/0466799995060671 |
| dc.contributor.referee1.fl_str_mv |
Queiroz Junior, Luiz Henrique Keng |
| dc.contributor.referee2.fl_str_mv |
Colnago, Luiz Alberto |
| dc.contributor.referee3.fl_str_mv |
Lião, Luciano Morais |
| dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/5383109693086058 |
| dc.contributor.author.fl_str_mv |
Rodrigues, Diego Alves |
| contributor_str_mv |
Queiroz Junior, Luiz Henrique Keng Martins, Felipe Terra Queiroz Junior, Luiz Henrique Keng Colnago, Luiz Alberto Lião, Luciano Morais |
| dc.subject.por.fl_str_mv |
RMN em estado sólido Efavirenz (EVZ) Oseltamivir Cálculos teóricos computacionais |
| topic |
RMN em estado sólido Efavirenz (EVZ) Oseltamivir Cálculos teóricos computacionais Solid state NMR Efavirenz (EVZ) Oseltamivir Computational theoretical calculations CIENCIAS EXATAS E DA TERRA::QUIMICA |
| dc.subject.eng.fl_str_mv |
Solid state NMR Efavirenz (EVZ) Oseltamivir Computational theoretical calculations |
| dc.subject.cnpq.fl_str_mv |
CIENCIAS EXATAS E DA TERRA::QUIMICA |
| description |
The commercialization of drugs most often occurs through their solid forms, and the caracteriscas of drugs should be kept throughout the process of production and storage. Upon this fact the characterization studies of the drugs in the solid state are in constant growth. NMR solid state high resolution can provide important complementary information current techniques, through the changes of the chemical shifts.The objective of this study is the characterization of the drug efavirenz (EVZ) and oseltamivir by the technique of nuclear magnetic resonance both in solution and solid state data together with the theoretical computations. Efavirenz drug was characterized by X diffraction (XRD), nuclear magnetic resonance in solution (1H NMR and 13C {1H}) and solid (CPMAS NMR and 13C CPTOSS e15N), and the use of theoretical calculations in solution GIAO using the model for unambiguous assignment of NMR signals. The same techniques of structural characterization and theoretical calculations were used in drug Oseltamivir, reeking the technique of X diffraction (XRD), and this drug hitherto considered amorphous.The experimental data obtained by NMR analyzes were consistent with the structure of drug efavirenz and oseltamivir; and the results of theoretical calculations were tabulated, a work of statistical analysis is performed in order to correlate the experimental data with the theoretical data, the analysis of the standard deviation (SD), mean deviation (MD), linear coefficient (R) . Notably, the theoretical values of the chemical shifts of 1H and 13C NMR in solution, obtained at the level of theory DFT/B3LYP, allowed for the drugs in question a considerable correlation with experimental values and permitted to associate a low computational cost of a good precision results.Thus using NMR experiments in solution 1D and 2D allies the results of computational theoretical calculations was possible the elucidation and assignment of all NMR signals of 1H and 13C of both drugs. efined experiments 1D solid state NMR (CP / TOSS and 13C CP / MASS de15N) allowed identification of these atoms in the solid state. Combined with theoretical calculations GIPAW provided valuable information on the molecules within the asymmetric unit of each drug. |
| publishDate |
2014 |
| dc.date.issued.fl_str_mv |
2014-09-01 |
| dc.date.accessioned.fl_str_mv |
2017-04-19T14:24:54Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
| format |
masterThesis |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
RODRIGUES, D. A. Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos. 2014. 97 f. Dissertação (Mestrado em Química) - Universidade Federal de Goiás, Goiânia, 2014. |
| dc.identifier.uri.fl_str_mv |
http://repositorio.bc.ufg.br/tede/handle/tede/7185 |
| dc.identifier.dark.fl_str_mv |
ark:/38995/0013000008m7b |
| identifier_str_mv |
RODRIGUES, D. A. Caracterização da fase cristalina dos antivirais efavirenz e oseltamivir por RMN e cálculos teóricos. 2014. 97 f. Dissertação (Mestrado em Química) - Universidade Federal de Goiás, Goiânia, 2014. ark:/38995/0013000008m7b |
| url |
http://repositorio.bc.ufg.br/tede/handle/tede/7185 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.relation.program.fl_str_mv |
663693921325415158 |
| dc.relation.confidence.fl_str_mv |
600 600 600 600 |
| dc.relation.department.fl_str_mv |
7826066743741197278 |
| dc.relation.cnpq.fl_str_mv |
1571700325303117195 |
| dc.relation.sponsorship.fl_str_mv |
2075167498588264571 |
| dc.rights.driver.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Universidade Federal de Goiás |
| dc.publisher.program.fl_str_mv |
Programa de Pós-graduação em Química (IQ) |
| dc.publisher.initials.fl_str_mv |
UFG |
| dc.publisher.country.fl_str_mv |
Brasil |
| dc.publisher.department.fl_str_mv |
Instituto de Química - IQ (RG) |
| publisher.none.fl_str_mv |
Universidade Federal de Goiás |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFG instname:Universidade Federal de Goiás (UFG) instacron:UFG |
| instname_str |
Universidade Federal de Goiás (UFG) |
| instacron_str |
UFG |
| institution |
UFG |
| reponame_str |
Repositório Institucional da UFG |
| collection |
Repositório Institucional da UFG |
| bitstream.url.fl_str_mv |
http://repositorio.bc.ufg.br/tede/bitstreams/96beb7a3-b407-49f6-a0fd-830688cd2cec/download http://repositorio.bc.ufg.br/tede/bitstreams/c19efe5a-17ec-4b82-9b40-bdfb69a296f6/download http://repositorio.bc.ufg.br/tede/bitstreams/eb9eb9dc-c505-4d92-b924-87ea5debe114/download http://repositorio.bc.ufg.br/tede/bitstreams/f1543613-8bd2-48b6-bf88-5d7ace88ae3c/download http://repositorio.bc.ufg.br/tede/bitstreams/2b847c8d-f354-49be-8744-d8816de2fd91/download |
| bitstream.checksum.fl_str_mv |
bd3efa91386c1718a7f26a329fdcb468 4afdbb8c545fd630ea7db775da747b2f d41d8cd98f00b204e9800998ecf8427e d41d8cd98f00b204e9800998ecf8427e 740d277eef5f559b08bdd1742e750f6e |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da UFG - Universidade Federal de Goiás (UFG) |
| repository.mail.fl_str_mv |
grt.bc@ufg.br |
| _version_ |
1846536696443699200 |